4
Changes in Ownership
MYRIAD GENETICS INC Filed Acc 0001471518-21-000002
Director sold 47,881 shares at $35.04 ($1,677,741)
- Director acquired 60,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Phanstiel S. Louise · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-05 | Exercise or conversion : show line 1 in the form | +30,000 | $25.39 | $761,700 | 109,527 | D |
| 2021-08-05 | Sale : show line 2 in the form | −47,881 | $35.04 | $1,677,741 | 61,646 | D |
| 2021-08-05 | Exercise or conversion : show line 3 in the form | +30,000 | $21.29 | $638,700 | 91,646 | D |
| Open-market sales · 47,881 sh · avg $35.04 · $1,677,741 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-08-05 | Exercise or conversion : show line 4 in the form Non-Qualified Stock Option (right to buy) | −30,000 | 0 | D |
| 2021-08-05 | Exercise or conversion : show line 5 in the form Non-Qualified Stock Option (right to buy) | −30,000 | 0 | D |
Loading xslF345X03/edgardoc.xml…